KZA kazia therapeutics limited
Add to My Watchlist 0.00% ! 8.0¢

Dr. Brastianos said at the 2020 Miami Breast Cancer Conference

  1. Rich&Poor
    1,206 Posts.
    lightbulb Created with Sketch. 941
    clock Created with Sketch.
    01/09/20
    21:54
    Post #: 47003396
    Genetics May Soon Guide Targeted Treatment of Brain Metastases.
    Article dated 25 May 2020 in the ASCO Post which has a ciculation of 30,000 ASCO members. - (Brastianos PK: Meet the faculty—Case discussions. 2020 Miami Breast Cancer Conference. Invited Lecture. Presented March 6, 2020).

    The first Interim data presentation from Dr Priscilla Brastianos regarding the ALLIANCE study, showing the efficacy of Paxalisib's PI3K/mTOR pathway inhibitors in Brain Metastases, will have a material effect on Kazia's future valuation.

    https://ascopost.com/issues/may-25-2020/genetics-may-soon-guide-targeted-treatment-of-brain-metastases/

    Regards.



    KZA Price at posting: $1.10 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 025 – Locksley rap video gives Hilltop Hoods run for money
right-arrow Created with Sketch.
NEWS Cells protected by Xolatryp through mitochondrial stabilisation
right-arrow Created with Sketch.
FBM Assays confirm strong gold anomalism at Canyon within Miriam Project
right-arrow Created with Sketch.
NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
3DA Amaero’s big move: Exclusive deal, big targets, and a lot on the line
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.